Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 14/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4730021 | 0.86 | TACR1 (0.38) | TACR1SLC6A4 | |
| SCHEMBL4732027 | 0.84 | TACR1 (0.38) | TACR1SLC6A4HSD11B1 | |
| SCHEMBL3998206 | 0.84 | PARP1 (0.40) | — | |
| SCHEMBL4000675 | 0.83 | TACR1 (0.33) | TACR1SLC6A4 | |
| SCHEMBL4731956 | 0.82 | TACR1 (0.46) | TACR1SLC6A4CCR2 | |
| SCHEMBL3997786 | 0.81 | KCNH2 (0.34) | TACR1SLC6A4 | |
| SCHEMBL4003970 | 0.81 | TACR1 (0.36) | TACR1SLC6A4SMYD3CCR2 | |
| SCHEMBL4730989 | 0.81 | CETP (0.38) | TACR1CCR2 | |
| SCHEMBL4728683 | 0.81 | KDM4E (0.40) | TACR1 | |
| SCHEMBL4730586 | 0.81 | TACR1 (0.34) | TACR1CYP2C9CYP2C19CYP3A4SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008045564-A2 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE CHEMOKINE CCR2 RECEPTOR | EPIX DELAWARE, INC. (US) | 2008-04-17 | — | — | WO | disclosed |